28 August - 01 September 2010, Stockholm - Sweden

Session Details

Poster session 3 : Cardiovascular prevention and rehabilitation: intervention and outcomes
Mon 30 Aug 08:30 - 12:30 Secondary cardiovascular prevention: interventions and outcomes Poster Session Posters - Zone A

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
08:30P2244Influence of age and gender of the treating physician on long-term medical therapy of Coronary Artery Disease (CAD): results from the Disease Management Program (DMP) CAD NorthrhineInes SCHWANG (Hamm, DE)
08:30P2245Genetic determinants of treatment benefit of ACE-inhibitor therapy in patients with stable coronary artery disease.Jasper BRUGTS (Rotterdam, NL)
08:30P2246Impact of smoking on cardiovascular events in patients with stable coronary disease receiving contemporary medical therapy: a post hoc analysis of the Treating to New Targets trialDavid WATERS (Sausalito, US)
08:30P2247Gender differences in treatment and control of risk factors in persons at high risk for cardiovascular disease: findings from the FINRISK Study.Hanna-Riikka LEHTO (Turku, FI)
08:30P2248Influenza vaccination reduces cardiovascular events in patients with acute coronary syndromeArintaya PHROMMINTIKUL (Chiang Mai, TH)
08:30P2249Effectiveness of non-pharmacological secondary prevention of coronary heart diseaseFalk MUELLER-RIEMENSCHNEIDER (Berlin, DE)
08:30P2250Germany lags behind other European Countries and Canada in LDL-cholesterol goal achievement according to existing guidelines: results of the Dyslipidemia International StudyAnselm Kai GITT (Ludwigshafen, DE)
08:30P2251Predictors of LDL-cholesterol goal achievement in secondary prevention in Europe and Canada: results of the Dyslipidemia International StudyAnselm Kai GITT (Ludwigshafen, DE)
08:30P2252Women with acute myocardial infarction without coronary stenoses on angiography receive similar subsequent medical treatment as men.Kim Wadt HANSEN (Hellerup, DK)
08:30P2253Impact of high density lipoprotein cholesterol after statin therapy on clinical outcomes after percutaneous coronary interventionSukmin SEO (Inchein, KR)
08:30P2254Real-life use, and effects on lipid levels, of lipid lowering treatments after acute myocardial infarction in SwedenKristina HAMBRAEUS (Falun, SE)
08:30P2255Improvement of vessel remodeling and plaque volume in patients with diabetes mellitus after rosuvastatin treatment -a serial analysis from the COSMOS study-Tadateru TAKAYAMA (Tokyo, JP)
08:30P2256Perspective study of patients with ischemic heart disease: impact of telecardiology on therapy adherence and smoking cessationRaffaele PICCARI (Rome, IT)
08:30P2257High risk for heart failure: diastolic dysfunction and left ventricular hypertrophy in the nurse-led intervention for less chronic heart failure (NIL-CHF) study cohortSimon STEWART (Melbourne, AU)
08:30P2258Peptic ulcer prevention by esomeprazole 20 mg and 40 mg once daily in patients taking low-dose acetylsalicylic acid for secondary cardiovascular preventionJames SCHEIMAN (Ann Arbor, US)
08:30P2259One-year persistence and adherence rates to secondary prevention drugs prescribed in-hospital in patients with acute coronary syndromes. The ALASCA StudyHector BUENO (Madrid, ES)
08:30P2260Depressive symptoms predict fatal and nonfatal end-points in arterial hypertension and coronary heart disease patients: results of a 3-year follow-up multicenter studyNana-Goar POGOSOVA (Moscow, RU)
08:30P2261Depressive symptoms predict death in arterial hypertension and coronary heart disease patients: results of a 3-year follow-up multicenter studyNana-Goar POGOSOVA (Moscow, RU)
08:30P2262Low endogenous serum testosterone and high asymmetric dimethylarginine levels are additively associated with carotid intima media thickness and progression of coronary artery disease Nikolaos IOAKIMIDIS (Athens, GR)
08:30P2263The effect of patient education on home-based rehabilitation on physical fitness in patients over 60 after acute myocardial infarction.Jolanta WOLKANIN-BARTNIK (Warszawa, PL)
08:30P2264Cardiac rehabilitation might reduce the late loss after implantation of drug-eluting stentsShunsuke SASAKI (Tokyo, JP)
08:30P2265Influence of age of patients and physicians on medical treatment of Coronary Artery Disease (CAD): results from the Disease Management Program (DMP) Northrhine.Ines SCHWANG (Hamm, DE)
08:30P2266Does feedback improve long-term control of blood pressure (RR) and LDL-cholesterol (LDL-C)? Results from the Disease Management Program (DMP) coronary artery disease (CAD) Northrhine.Ines SCHWANG (Hamm, DE)
08:30P2267DYSlipidaemia International Study (DYSIS) - IrelandStephen HORGAN (Dublin, IE)
08:30P2268Interval training versus continuous endurance training on 24-h blood pressure control and insulin resistance of diabetic patients with coronary artery disease. Giuseppe CAMINITI (Rome, IT)
08:30P2269(W)Overcoming the barriers; increasing completion rates of indigenous cardiac rehabilitation through partnershipTo Be Announced
08:30P2270Low-dose acetylsalicylic acid and concomitant prescription patterns of clopidogrel and proton pump inhibitors in UK primary careHector BUENO (Madrid, ES)
08:30P2271Cardiopulmonary exercise testing parameters to predict pump failure and arrhythmic risk: different parameteres for different events?Rita THEOTONIO (Lisbon, PT)
08:30P2272A dedicated PPCI follow up clinic improves secondary prevention, SCD risk stratification and management of bystander disease when compared with traditional post MI follow upJoanna LIM (London, GB)
08:30P2273Structured care in a Post-ACS clinic using the alphabet strategy improves correspondence communication from specialist care to general practice.James Douglas LEE (Ufton, GB)
08:30P2274Effects of lifestyle interventions on high risk patients after percutaneous coronary intervention-single center experienceMarina LICINA (Belgrade, RS)
08:30P2275Hyperuricemia and increased risk of cardiac eventsYafim BRODOV (Haifa, IL)
08:30P2276Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin c in patients with renal insufficiency undergoing cardiac catheterizationYuki ISHIBASHI (Kawasaki, JP)
08:30P2277The effects of niacin on platelet biomarkers in humans: potential link to outcome benefit?Victor L SEREBRUANY (Towson, US)
08:30P2278A group-based multi-professional education programme for family members of patients with chronic heart failure: effects on knowledge and patients' health care utilzation.Caroline LOFVENMARK (Stockholm, SE)
08:30P2279Management of acute myocardial infarction in France: results from the EOLE cohortDaniel THOMAS (Paris Cedex 13, FR)
08:30P2280Secondary prevention of major adverse cardiovascular events in patients with platelet membrane glycoprotein VI polymorphismZuzana MOTOVSKA (Prague, CZ)
08:30P2281The long-chain pentraxin-3 (PTX3) predicts short-term functional recovery of rehabilitation in patients with cardiac surgeryRoberto LATINI (Milan, IT)
08:30P2282The influence of regular physical activity to cardiovascular parameters and adrenergic activity in seniors groupDaniel SLIZ (Warsaw, PL)
08:30P2283Effects of exercise training on functional capacity and neurovascular control in middle-aged and old heart failure patientsLigia ANTUNES-CORREA (Sao Paulo, BR)
08:30P2284Impact of obesity and gender on the functional outcome of the stationary rehabilitation of patients with coronary heart diseaseFranjo BABORSKI (Krapinske Toplice, HR)
08:30P2285Physical rehabilitation in acute period of complicated myocardial infarction with following home-based continuationElena KOLESNIKOVA (Moscow, RU)
08:30P2286Stretching exercise improves vascular endothelial function and peripheral circulation in patients with ischemic heart diseaseKazuki HOTTA (Sagamihara, JP)
08:30P2287Effects of daily functional training vs. standard rehabilitation on six minute walk distance and quality of life in very old patients after coronary artery bypass graft surgeryJohn Clemens BUSCH (Bad Rothenfelde, DE)
08:30P2288Is chronotropic incompetence associated with poor outcome in cardiac rehabilitation?Ana Sofia CORREIA (Porto, PT)
08:30P2289Cardiac rehabilitation in very old patients: an overview from the italian SurveY on cardiac rehabilitation (ISYDE-2008 survey)Francesco GIALLAURIA (Naples, IT)
08:30P2290Home based exercise training in addition to neurohormonal modulation treatment in ischemic chronic heart failureEleonora VATAMAN (Chisinau (Kishinev), MD)
08:30P2291Endothelial progenitor cells mobilization and inflammation after cardiac rehabilitation on patients undergoing PCI after ACS Francesca CESARI (Florence, IT)
08:30P2292High intensity aerobic exercise training induces similar or even superior blood pressure reducing effects in controlled hypertensive patientsArtur HERDY (Florianopolis, BR)
08:30P2293Do all left ventricular systolic dysfunction groups benefit equally from exercise training in cardiac rehabilitation?Hannah STALLARD (Llantrisant, GB)
08:30P2294Predictors of depression and wellbeing 4 years after an outpatient cardiac rehabilitation programMatthias WACHTER (Aarau, CH)
08:30P2295Cardiovascular responses during acute inspiratory muscle exercise in heart failure patientsMaria IRIGOYEN (Sao Paulo, BR)
08:30P2296Role of exercise training on the cardiac and autonomic adjustments to myocardial infarction in diabetesTo Be Announced, Katia DE ANGELIS (Sao Paulo, BR)
08:30P2297Constructing and validating a scoring model to determine a meaningful clinical improvement in quality of life for patients admitted with an ACS undergoing PCIAmeet BAKHAI (Barnet, GB)
08:30P2298Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery diseaseCornelius MUELLER (Bonn, DE)
08:30P2299Short- and long-term health outcomes after different exercise-based cardiac rehabilitation programmesWerner BENZER (Feldkirch, AT)
08:30P2300Association of tai chi and endurance training in the rehabilitation of elderly patients with chronic heart failure: a randomized pilot study.Giuseppe CAMINITI (Rome, IT)